Cambrex Corp. has acquired a 51% stake in Zenara Pharma for $20 million. Zenara is pharmaceutical company based in Hyderabad, India, focused on the formulation of final dosage form products. Under the stock purchase agreement, Cambrex will acquire the remaining 49% in early 2016 at a value based on a combination of 2015 earnings, taxes, depreciation and amortization. The company will be known as Cambrex Zenara. With the acquisition Cambrex gains entry into the growing Nicotine Replacement The...